BSX
67
-2
JNJ
56
5
VRTX
55
-3
MCHP
42
3
AEE
78
-4
LRCX
48
-2
UPS
32
-3
LEG
22
9
ESS
47
-3
PDCO
69
-2
TRV
49
-3
JBHT
35
2
MSI
47
4
MS
53
-9
AON
73
-2
CL
50
2
ILMN
25
2
ADSK
52
3
EXC
72
-4
COF
62
2
BSX
67
-2
JNJ
56
5
VRTX
55
-3
MCHP
42
3
AEE
78
-4
LRCX
48
-2
UPS
32
-3
LEG
22
9
ESS
47
-3
PDCO
69
-2
TRV
49
-3
JBHT
35
2
MSI
47
4
MS
53
-9
AON
73
-2
CL
50
2
ILMN
25
2
ADSK
52
3
EXC
72
-4
COF
62
2
Financhill
Back

Harte-Hanks 10K Form

Sell
18

HHS
Harte-Hanks

Last Price:
$4.82
Seasonality Move:
3.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HHS News And Ratings

See the #1 stock for the next 7 days that we like better than HHS

HHS Financial Statistics

Sales & Book Value

Annual Sales: $185.2M
Cash Flow: $3.4M
Price / Cash Flow: 167.22
Annual Sales: $2.95
Price / Book: 1.63

Profitability

EPS (TTM): -4.17000
Net Income (TTM): $-30.3M
Gross Margin: $128.6M
Return on Equity: -146.84%
Return on Assets: -27.25%

Harte-Hanks Earnings Forecast

Key Harte-Hanks Financial Ratios

  • The Gross Profit Margin over the past 33 years for HHS is 69.42%.
  • The Selling, General & Administrative Expenses for HHS have been equal to 62.92% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 1.19% of Operating Income.
  • The Net Earning history of HHS is -16.36% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 20 years.

Harte-Hanks Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Media
Sector: Communication Services
Current Symbol: HHS
CUSIP: 416196
Website: hartehanks.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.53
Quick Ratio: 1.44

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

HHS Technical Analysis vs Fundamental Analysis

Sell
18
Harte-Hanks (HHS) is a Sell

Is Harte-Hanks a Buy or a Sell?

  • Harte-Hanks stock is rated a Sell
    The current Harte-Hanks [HHS] share price is $4.81. The Score for HHS is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.